A detailed history of Eaton Vance Management transactions in West Pharmaceutical Services Inc stock. As of the latest transaction made, Eaton Vance Management holds 180,971 shares of WST stock, worth $59.6 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares
180,971
Previous 99,737 81.45%
Holding current value
$59.6 Million
Previous $30.2 Million 47.67%
% of portfolio
0.07%
Previous 0.04%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022

BUY
$246.08 - $343.65 $20 Million - $27.9 Million
81,234 Added 81.45%
180,971 $44.5 Million
Q2 2022

Aug 15, 2022

SELL
$280.61 - $420.45 $322,420 - $483,097
-1,149 Reduced 1.14%
99,737 $30.2 Million
Q1 2022

May 16, 2022

BUY
$357.49 - $445.92 $10.9 Million - $13.6 Million
30,532 Added 43.4%
100,886 $41.4 Million
Q4 2021

Feb 14, 2022

BUY
$402.25 - $471.34 $399,032 - $467,569
992 Added 1.43%
70,354 $32.3 Million
Q3 2021

Nov 15, 2021

BUY
$363.01 - $468.47 $967,784 - $1.25 Million
2,666 Added 4.0%
69,362 $28.8 Million
Q2 2021

Aug 16, 2021

BUY
$284.77 - $363.2 $1.67 Million - $2.14 Million
5,879 Added 9.67%
66,696 $24 Million
Q1 2021

May 17, 2021

BUY
$257.29 - $307.53 $551,115 - $658,729
2,142 Added 3.65%
60,817 $17.1 Million
Q4 2020

Feb 12, 2021

BUY
$261.16 - $301.66 $636,185 - $734,843
2,436 Added 4.33%
58,675 $16.6 Million
Q3 2020

Nov 13, 2020

BUY
$224.99 - $288.02 $368,083 - $471,200
1,636 Added 3.0%
56,239 $15.5 Million
Q2 2020

Aug 13, 2020

BUY
$149.8 - $227.17 $491,344 - $745,117
3,280 Added 6.39%
54,603 $12.4 Million
Q1 2020

May 14, 2020

SELL
$128.96 - $174.76 $419,506 - $568,494
-3,253 Reduced 5.96%
51,323 $7.81 Million
Q4 2019

Feb 11, 2020

SELL
$137.6 - $151.21 $3,715 - $4,082
-27 Reduced 0.05%
54,576 $8.2 Million
Q3 2019

Nov 14, 2019

SELL
$121.41 - $150.02 $6.03 Million - $7.45 Million
-49,690 Reduced 47.64%
54,603 $7.74 Million
Q2 2019

Aug 16, 2019

SELL
$111.27 - $125.15 $1.65 Million - $1.85 Million
-14,788 Reduced 12.42%
104,293 $13.1 Million
Q1 2019

May 14, 2019

SELL
$94.53 - $110.2 $11 Million - $12.8 Million
-116,461 Reduced 49.44%
119,081 $13.1 Million
Q4 2018

Feb 07, 2019

SELL
$93.0 - $123.98 $2.82 Million - $3.76 Million
-30,316 Reduced 11.4%
235,542 $23.1 Million
Q3 2018

Nov 13, 2018

SELL
$98.01 - $123.47 $594,626 - $749,092
-6,067 Reduced 2.23%
265,858 $32.8 Million
Q2 2018

Aug 10, 2018

SELL
$83.32 - $101.88 $2.16 Million - $2.64 Million
-25,896 Reduced 8.7%
271,925 $27 Million
Q1 2018

May 07, 2018

BUY
$85.56 - $102.4 $820,520 - $982,016
9,590 Added 3.33%
297,821 $26.3 Million
Q4 2017

Feb 12, 2018

SELL
$91.65 - $101.65 $1.31 Million - $1.46 Million
-14,314 Reduced 4.73%
288,231 $28.4 Million
Q3 2017

Nov 13, 2017

BUY
$84.54 - $96.75 $25.6 Million - $29.3 Million
302,545
302,545 $29.1 Million

Others Institutions Holding WST

About WEST PHARMACEUTICAL SERVICES INC


  • Ticker WST
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 74,033,000
  • Market Cap $24.4B
  • Description
  • West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers sto...
More about WST
Track This Portfolio

Track Eaton Vance Management Portfolio

Follow Eaton Vance Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Eaton Vance Management, based on Form 13F filings with the SEC.

News

Stay updated on Eaton Vance Management with notifications on news.